O-01: Pharmacotherapy for Insomnia: Population Use and Efficacy of Novel Compounds

Friday, August 28, 2020, 11:30 AM-12:15 PM

Abstract NumberAbstract Title
0474Long-Term Efficacy and Safety of Lemborexant in Elderly Adults with Insomnia Disorder: Results from SUNRISE-2
0487Effects of Suvorexant on Sleep Architecture in Patients with Alzheimer’s Disease and Insomnia
0502Safety, Tolerability, and Efficacy of a Novel, Highly Potent and Selective Partial Agonist for Nociceptin/Orphanin-FQ Peptide (NOP) Receptors in Patients with Insomnia Disorder
0511Patterns of Concomitant Over-the-Counter, Natural Product and Prescription Sleep Aid Use: A Population-Based Study